Literature DB >> 10768323

Target pressure--glaucomatologists' holey grail.

K Singh, G Spaeth, T Zimmerman, D Minckler.   

Abstract

Mesh：

Year:  2000        PMID： 10768323     DOI： 10.1016/s0161-6420(00)00021-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

Review 1.  Evolving paradigms in the medical treatment of glaucoma.

Authors:  John S Cohen; Anup K Khatana; Linda J Greff
Journal:  Int Ophthalmol       Date:  2006-03-07       Impact factor: 2.031

2.  A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension.

Authors:  S M Whitcup; L B Cantor; A M VanDenburgh; K Chen
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

3.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30

4.  Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.

Authors:  Lawrence D Goldberg; John Walt
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

5.  Medical management of glaucoma: principles and practice.

Authors:  Kuldev Singh; Anurag Shrivastava
Journal:  Indian J Ophthalmol       Date:  2011-01       Impact factor: 1.848
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.